Mayo Clinic Cancer Center Renews NCI Research Funding
Mayo Clinic Cancer Center has successfully renewed funding for its Cancer Center Support Grant from the National Cancer Institute. The NCI grant award provides approximately $28.7 million in funding over five years through 2024, which will mark the center’s 49th year of NCI funding. The NCI awards Cancer Support Grants to institutions that demonstrate a reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these areas.
The NCI also renewed Mayo Clinic Cancer Center’s designation as an NCI comprehensive cancer center. To earn this distinction, an institution must demonstrate scientific leadership, resources, and depth and breadth of research in basic, clinical and/or population science, as well as substantial transdisciplinary research.
Currently, NCI has recognized Mayo Clinic Cancer Center as the only comprehensive cancer center with three geographic sites in Arizona, Florida and Minnesota; and it is one of 51 NCI-designated comprehensive cancer centers across the country.
“We’re pleased that the NCI recognized our strong performance over past five years,” says Robert Diasio, M.D., director of the Mayo Clinic Cancer Center. "These results would not be possible were it not for the efforts of hundreds of clinicians, researchers and support staff who come to work every day looking to improve the lives of patients with cancer.”
Mayo Clinic Cancer Center is an independent multidisciplinary program that encompasses cancer practice, cancer research and cancer education activities across Mayo Clinic. The NCI Cancer Center Support Grant has provided more than $146 million to Mayo Clinic Cancer Center over the past 44 years.